v3.25.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Current assets    
Cash and cash equivalents $ 41,739 $ 121,330
Short-term investments 72,416 26,004
R&D benefit receivable 19,957 24,396
Other current assets 14,356 14,664
Trade receivables 85 972
Total current assets 148,553 187,366
Property, plant and equipment 1,775 1,818
Operating lease right-of-use asset 58 157
Goodwill 10,617 9,392
Other intangible assets 317 312
Other long-term assets 3,913 3,590
Total assets 165,233 202,635
Current liabilities    
Contract liabilities (457) (306)
Trade and other payables (14,311) (16,399)
Operating lease liabilities, current 0 (117)
Total current liabilities (14,768) (16,822)
Contract liabilities (56,310) (51,790)
Total liabilities (71,078) (68,612)
Commitments and contingencies (Note 11)
Shareholders' equity    
Ordinary shares - par value 0.05 per share; 141,701,848 shares issued at June 30, 2025 (December 31, 2024: 141,674,074) (10,290) (10,288)
Additional paid-in capital (615,113) (609,560)
Accumulated deficit 529,844 474,044
Accumulated other comprehensive loss 1,404 11,781
Total shareholders' equity (94,155) (134,023)
Total liabilities and shareholders' equity $ (165,233) $ (202,635)